Your search for proton pump inhibitor returned 31 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Mpr-drug-news remove
Da Hee Han, PharmD remove

Your search for proton pump inhibitor returned 31 results

Sort Results:

Relevant Recent
News

Proton Pump Inhibitor Use May Up Death Risk

The authors found that compared to the use of H2RA therapy, patients initiated on PPI therapy had a 25% increased risk of death (hazard ratio [HR] 1.25, 95% CI: 1.23-1.28).
News

FDA Expands Dexilant Use for Younger GERD Patients

Takeda announced that the Food and Drug Administration (FDA) has approved Dexilant (dexlansoprazole) delayed-release capsules and Dexilant SoluTab delayed-release orally-disintegrating tablets for patients aged 12-17 years with gastroesophageal reflux disease (GERD).
News

Some Antacids Linked to Heart Attack Risk

Use of proton pump inhibitors (PPIs) increase the risk of an adult experiencing a heart attack by 16 to 21 percent compared to those who don't use commonly prescribed antacids, a large study has found.
News

Myopathy: Another Side Effect of PPIs?

Limited research published in Annals of Pharmacotherapy suggests that use of proton pump inhibitors (PPI) is associated with myopathy-like symptoms without long-term effects after discontinuation.
Generics News

Dr. Reddy’s Launches Generic Nexium

Dr. Reddy's Laboratories announced the launch of Esomeprazole Magnesium Delayed-Release Capsules, the generic version of AstraZeneca's Nexium Delayed-Release Capsules.
Generics News

FDA Approves First Generic Nexium

The Food and Drug Administration (FDA) has approved Ivax Pharmaceutical's Esomeprazole Magnesium Delayed-Release Capsules, the first generic version of AstraZeneca's Nexium.